Belsomra costs $450+ per month without insurance. Learn how to save with coupons, savings cards, patient assistance programs, and discount tips for 2026.
Belsomra (Suvorexant) is one of the more expensive sleep medications on the market. Without insurance or discount programs, you can expect to pay:
That's roughly $15 to $18 per pill — which adds up to over $5,400 to $6,600 per year.
The high price is largely because there is no generic version of Belsomra. The medication is still under Merck's patent protection, and generic Suvorexant is not expected until 2029 to 2033. Until then, every Belsomra prescription is for the brand-name product.
The good news is that there are several ways to significantly reduce what you pay. Let's go through every option.
Merck offers a manufacturer savings card for Belsomra that can dramatically reduce your copay.
This is the single best option for commercially insured patients. If your insurance covers Belsomra but leaves you with a high copay (say $50 to $150), the Merck Savings Card can bring that down to $0.
If you are uninsured or underinsured and can't afford Belsomra, Merck's patient assistance program may provide the medication completely free of charge.
Patient assistance programs are one of the most underused resources in healthcare. If you don't have insurance or your insurance doesn't cover Belsomra, this should be your first call.
Prescription discount cards can reduce the cash price of Belsomra if you're paying out of pocket. Here are the major options:
Additional discount cards to check include RxSaver, Optum Perks, BuzzRx, and America's Pharmacy. Savings on brand-name medications like Belsomra are typically more modest than for generics, but it's still worth comparing.
Important note: Discount cards are not insurance. They negotiate reduced cash prices with pharmacies. You cannot combine them with insurance — use one or the other for any given prescription.
If you have health insurance, getting Belsomra covered is possible but may require some effort:
Contact your insurance company or check their formulary online to see if Belsomra is covered. It's typically on Tier 3 (preferred brand) or Tier 4 (non-preferred/specialty), which means higher copays.
Most plans require prior authorization for Belsomra. Your doctor will need to submit paperwork showing:
If your insurance denies coverage, you have the right to appeal. Ask your doctor to provide additional clinical documentation. Many denials are overturned on appeal.
Medicare Part D plans may cover Belsomra, but coverage varies widely by plan. Check the plan's formulary during open enrollment. Copays for brand-name medications on Medicare can be significant — the Merck Savings Card is not valid with Medicare.
If your insurance covers Belsomra, mail-order pharmacies can offer savings:
Check with your insurance to see which mail-order pharmacy they partner with (Express Scripts, CVS Caremark, OptumRx, etc.).
If cost is the primary barrier and you're flexible on medication, generic alternatives are dramatically cheaper:
These medications work differently from Belsomra, so talk to your doctor before switching. Read our full comparison in the alternatives to Belsomra guide.
Here's how Belsomra compares to alternatives on a monthly basis:
Belsomra is expensive at $450 to $550 per month, but you don't have to pay full price. If you have commercial insurance, start with the Merck Savings Card for potential $0 copay. If you're uninsured, apply for the Merck Patient Assistance Program for free medication. Use discount cards like GoodRx for the best cash price, and explore mail-order for convenience and savings.
If cost remains a barrier, talk to your doctor about generic alternatives that may work just as well for your insomnia at a fraction of the price.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
